Delivery Order SPE2DB24D8002-SPE2DB25FJNTF
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,266.06 fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to supply a...
This federal contract award, valued at $3,368.79, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a performance period extending through January 16, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a ceiling value of $2,147.04, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 14, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,298.29, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It is a firm fixed-price contract with a performance period extending to March 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,686.83, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, having been awarded a significant Indefinite...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJMRZ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Firm Fixed Price Delivery Order, is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a ceiling value of $4,112.43 and a completion date of November 14, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,497.85 Firm Fixed Price contract is for the delivery of 4566188821 - XULANE 150-35 MCG/DAY PATCH 3S, with a period of performance through October 24, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a range...
This is a federal contract award (SPE2DX15D8003|SPE2DX24F7C1V) from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The $13,204.40 firm fixed-price delivery order contract has a period of performance through December 29, 2023. Dakota Drug, Inc. is a key supplier to DLA, holding a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $1,915.11 and a performance period ending on March 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,387.30 contract is for the provision of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This award does not have a set-aside designation. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the U.S. Department of...